Literature DB >> 15694967

Endometrium from women with and without endometriosis, and peritoneal, ovarian and bowel endometriosis, show different c-kit protein expression.

Catherine Uzan1, Annie Cortez, Charlotte Dufournet, Raffaèle Fauvet, Jean-Pierre Siffroi, Emile Daraï.   

Abstract

BACKGROUND: Endometriosis is defined by the presence of endometrium outside the uterus. Changes in the expression of the proto-oncogene c-kit are associated with aggressive behaviour of both benign and malignant tumours, but there are few data on its c-kit expression in endometriosis. Here we examined c-kit expression in endometrium and endometriotic tissue.
METHODS: Immunohistochemistry was used for qualitative and semi-quantitative (mean+/-S.D. positive cells) analysis of c-kit expression in endometrium from women with (n=9) and without endometriosis (n=18), and in peritoneal (n=20), ovarian (n=20) and colorectal endometriosis (n=20).
RESULTS: Semi-quantitative c-kit expression was higher in endometrial glandular cells from women with endometriosis than from women without endometriosis (15.0+/-14.6% versus 3.9+/-7.4%, p=0.01). No difference in c-kit expression was found in qualitative analysis and according to the phase of the menstrual cycle. C-kit expression values in peritoneal, ovarian and colorectal endometriosis were 2.0+/-3.8%, 2.0+/-4.1% and 21.7+/-18.4%, respectively. Qualitative and semi-quantitative c-kit expression was higher in colorectal endometriosis than in peritoneal and ovarian endometriosis (p<0.001); no difference was found between ovarian and peritoneal endometriosis. No c-kit expression was detected in stromal cells of either endometrium or endometriotic tissue.
CONCLUSION: These results suggest that the c-kit/stem cell factor axis is involved in the pathogenesis of endometriosis. Strong c-kit protein expression was associated with invasive endometriotic lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15694967     DOI: 10.1016/j.jri.2004.09.002

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  5 in total

1.  Immunolocalization of stem/progenitor cell biomarkers Oct-4, C-kit and Musashi-1 in endometriotic lesions.

Authors:  Flavia R Oliveira; Maíra Casalechi; Márcia M Carneiro; Ivete de Ávila; Cynthia Dela Cruz; Helen L Del Puerto; Aroldo F Camargos; Maurício S Abrão; Fernando M Reis
Journal:  Mol Biol Rep       Date:  2021-09-01       Impact factor: 2.316

2.  Pelvic endometriosis is rarely associated with ovarian borderline tumours, cytologic and architectural atypia: a clinicopathologic study.

Authors:  Mohamed Ali Bedaiwy; Mahmoud Rezk Abd-Elwahed Hussein; Charles Biscotti; Tommaso Falcone
Journal:  Pathol Oncol Res       Date:  2008-06-25       Impact factor: 3.201

Review 3.  Endometrial biomarkers for the non-invasive diagnosis of endometriosis.

Authors:  Devashana Gupta; M Louise Hull; Ian Fraser; Laura Miller; Patrick M M Bossuyt; Neil Johnson; Vicki Nisenblat
Journal:  Cochrane Database Syst Rev       Date:  2016-04-20

4.  Unremitting cell proliferation in the secretory phase of eutopic endometriosis: involvement of pAkt and pGSK3β.

Authors:  Yanira Franco-Murillo; José Antonio Miranda-Rodríguez; Erika Rendón-Huerta; Luis F Montaño; Gerardo Velázquez Cornejo; Lucila Poblano Gómez; Francisco Javier Valdez-Morales; Ignacio Gonzalez-Sanchez; Marco Cerbón
Journal:  Reprod Sci       Date:  2014-09-06       Impact factor: 3.060

5.  Does the Use of the "Proseek® Multiplex Oncology I Panel" on Peritoneal Fluid Allow a Better Insight in the Pathophysiology of Endometriosis, and in Particular Deep-Infiltrating Endometriosis?

Authors:  Alexandra Perricos; René Wenzl; Heinrich Husslein; Thomas Eiwegger; Manuela Gstoettner; Andreas Weinhaeusel; Gabriel Beikircher; Lorenz Kuessel
Journal:  J Clin Med       Date:  2020-06-26       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.